At Alveo, we understand the importance of access to cutting-edge molecular testing and cloud-based data analytics for rapid diagnosis and management of infectious diseases. Alveo has re-envisioned the capabilities of molecular sensing and diagnostics with our be.well™ System platform, which is customized to detect a wide range of infectious diseases, including COVID-19. With be.well™, we will Know Sooner, Act Faster™.